SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-021197
Filing Date
2018-08-10
Accepted
2018-08-10 07:31:46
Documents
60
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q eigr-10q_20180630.htm 10-Q 1582150
2 EX-10.1 eigr-ex101_262.htm EX-10.1 655615
3 EX-10.2 eigr-ex102_308.htm EX-10.2 82048
4 EX-10.3 eigr-ex103_307.htm EX-10.3 213908
5 EX-10.4 eigr-ex104_259.htm EX-10.4 132058
6 EX-31.1 eigr-ex311_8.htm EX-31.1 16848
7 EX-31.2 eigr-ex312_7.htm EX-31.2 16909
8 EX-32.1 eigr-ex321_9.htm EX-32.1 5744
9 GRAPHIC gf5ws1lmgalh000002.jpg GRAPHIC 1484
10 GRAPHIC gf5ws1lmgalh000001.jpg GRAPHIC 1484
  Complete submission text file 0001564590-18-021197.txt   6257344

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT eigr-20180630.xml EX-101.INS 1124026
12 XBRL TAXONOMY EXTENSION SCHEMA eigr-20180630.xsd EX-101.SCH 38410
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eigr-20180630_cal.xml EX-101.CAL 35495
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eigr-20180630_def.xml EX-101.DEF 106091
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE eigr-20180630_lab.xml EX-101.LAB 271499
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eigr-20180630_pre.xml EX-101.PRE 207330
Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306
Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36183 | Film No.: 181006999
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1